Tumor response to ionizing radiation combined with antiangiogenesis or vascular targeting agents: exploring mechanisms of interaction.
about
Overcoming the hypoxic barrier to radiation therapy with anaerobic bacteriaTherapeutic Electromagnetic Field (TEMF) and gamma irradiation on human breast cancer xenograft growth, angiogenesis and metastasisRegulation of Akt signaling by sirtuins: its implication in cardiac hypertrophy and agingTargeting Artificial Tumor Stromal Targets for Molecular Imaging of Tumor Vascular HypoxiaOptical Imaging of Tumor Response to Hyperbaric Oxygen Treatment and Irradiation in an Orthotopic Mouse Model of Head and Neck Squamous Cell Carcinoma.Multimodality treatment of brain metastases from renal cell carcinoma in the era of targeted therapyThe Intercellular Metabolic Interplay between Tumor and Immune CellsQuantitative ultrasound imaging of therapy response in bladder cancer in vivo.Intraoperative Contrast Enhanced Ultrasound Evaluates the Grade of Glioma.Microbubble and ultrasound radioenhancement of bladder cancer.Endothelial Caveolin-1 regulates the radiation response of epithelial prostate tumors.pH-weighted molecular imaging of gliomas using amine chemical exchange saturation transfer MRIImaging the intratumoral-peritumoral extracellular pH gradient of gliomas.Acute tumor response to ZD6126 assessed by intrinsic susceptibility magnetic resonance imaging.Three-dimensional imaging of xenograft tumors using optical computed and emission tomography.Progress of clinical research on targeted therapy combined with thoracic radiotherapy for non-small-cell lung cancerInhibition of tumor growth and metastasis by a combination of Escherichia coli-mediated cytolytic therapy and radiotherapySunitinib plus androgen deprivation and radiation therapy for patients with localized high-risk prostate cancer: results from a multi-institutional phase 1 study.Autotaxin and LPA receptors represent potential molecular targets for the radiosensitization of murine glioma through effects on tumor vasculature.Regulation of HIF-1alpha stability through S-nitrosylation.Cytosolic phospholipase A2 and lysophospholipids in tumor angiogenesisReport from the Radiation Therapy Committee of the Southwest Oncology Group (SWOG): Research Objectives Workshop 2008.Rectal cancer treatment: improving the picture.In vivo optical imaging of tumor and microvascular response to ionizing radiationCombining targeted agents with modern radiotherapy in soft tissue sarcomas.Phase II study of neoadjuvant bevacizumab and radiotherapy for resectable soft tissue sarcomas.Dynamics of tumor hypoxia in response to patupilone and ionizing radiationA phase Ib/II translational study of sunitinib with neoadjuvant radiotherapy in soft-tissue sarcoma.Phase II study of bevacizumab in combination with docetaxel and radiation in locally advanced squamous cell carcinoma of the head and neck.Monitoring sunitinib-induced vascular effects to optimize radiotherapy combined with soy isoflavones in murine xenograft tumorImmunoimaging of CXCR4 expression in brain tumor xenografts using SPECT/CTHypoxia-inducible factor-1α protects cervical carcinoma cells from apoptosis induced by radiation via modulation of vascular endothelial growth factor and p53 under hypoxia.A phase 1b trial of the combination of the antiangiogenic agent sunitinib and radiation therapy for patients with primary and metastatic central nervous system malignancies.Liposome transfected to plasmid-encoding endostatin gene combined with radiotherapy inhibits liver cancer growth in nude mice.CT perfusion as an imaging biomarker in monitoring response to neoadjuvant bevacizumab and radiation in soft-tissue sarcomas: comparison with tumor morphology, circulating and tumor biomarkers, and gene expression.Combined-modality radioimmunotherapy: synergistic effect of paclitaxel and additive effect of bevacizumabSynergistic Effect of Anti-Angiogenic and Radiation Therapy: Quantitative Evaluation with Dynamic Contrast Enhanced MR Imaging.Molecular targets for tumor radiosensitization.Hypoxia-activated chemotherapeutic TH-302 enhances the effects of VEGF-A inhibition and radiation on sarcomas.Chemokine CCL17 induced by hypoxia promotes the proliferation of cervical cancer cell.
P2860
Q24569648-421164E5-E30D-4AE9-8E5C-F2E7482A75F9Q24815616-66E6E1D1-46E8-4D13-8AF0-9858E08D4B1EQ26998765-9D2D98B3-59F5-4C56-A983-4182EDDD5E9FQ27300346-D24A316B-F305-401A-B936-71E23AC32935Q27313985-15B6B202-9D96-47CC-BB94-11F68B122FA5Q28077050-8A7905A2-55D1-48DB-9C23-9A917AC27377Q28391079-16A16EF5-5ABE-46F9-A774-4FE9905BD6BFQ30383168-E08E24AB-F3E6-443F-81D1-239013C546F5Q30386016-2AF93354-2C74-4363-9DA3-D2ABF131C885Q30451819-37D1B42A-ECB0-496A-9895-670100D7F03EQ30652492-AD83E536-B9E5-466C-AB92-DDED3C91E729Q30976860-3A3F7DEE-55EF-421D-BC97-F397837468DAQ31036207-6B7CE1AF-8050-486E-ABD4-D7F3200C1954Q33217481-E6DDAF6F-863D-4E96-83DB-C7A9761C70C9Q33259416-C5B6C4D6-571A-43C2-AF58-EF39F775197FQ33720025-3C5D7B66-ECAA-44D0-BD39-4CBFBD003E09Q33731187-FA53F5E4-F8CA-47DA-8FC2-C05E20D91075Q33918464-CCEED6CA-AFC4-462A-840C-26544764F2CEQ33974891-41048583-5355-4A44-8597-D03DF1350DD8Q34001616-19563A68-C26A-4B9D-BF89-320D171078FFQ34145860-D028443C-500C-4D4F-ACE4-BB98D1920DC5Q34298754-860C1271-ECA9-4158-98FA-79B56A2375B7Q34382761-1AB6B2DC-36D4-49DB-A080-37681CB28853Q34395430-6B2BC621-B836-4162-88E5-A514C3724524Q34396047-3B958413-2ED0-4F57-B044-099971920FDFQ34491021-EECF3738-B31C-4C47-9CB4-E8D98D765DB3Q34516719-CAF0DEAB-9A1D-4FB0-BC3E-20B18A25F6DCQ34687036-1F0E4DB4-56EC-4DAF-81FA-9C94B722C902Q34749411-E5DBEE52-806B-4D48-8302-26537C6190E7Q34754097-AB4F2926-B0D6-4191-9D93-BEDA4DFB2182Q34787997-294645C8-0D54-4F70-9E5A-7FEB322B4564Q35048388-7DDC8004-78EF-4A6F-8054-36EEFB14C0B8Q35207344-FB545666-EEF0-46A5-B585-E24AC8EE88CFQ35615977-D2050929-8A88-48E5-BC77-89016654EC5DQ35776891-1633FE2C-A56B-476E-9E7C-944392267E43Q35842769-F173497A-8A7E-4DAA-A239-139590DE02B5Q35919459-EBEBDD71-0EA7-4081-9F3C-B6A3B7C9DDD7Q36126009-44436D4B-8292-42BB-B6C7-3A0E88BCDC10Q36286658-51BE51D1-5C0C-4794-8A18-4BA1820B747CQ36309396-1D4A7D63-D785-402E-BA4F-1477A323C107
P2860
Tumor response to ionizing radiation combined with antiangiogenesis or vascular targeting agents: exploring mechanisms of interaction.
description
2003 nî lūn-bûn
@nan
2003 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Tumor response to ionizing rad ...... ing mechanisms of interaction.
@ast
Tumor response to ionizing rad ...... ing mechanisms of interaction.
@en
type
label
Tumor response to ionizing rad ...... ing mechanisms of interaction.
@ast
Tumor response to ionizing rad ...... ing mechanisms of interaction.
@en
prefLabel
Tumor response to ionizing rad ...... ing mechanisms of interaction.
@ast
Tumor response to ionizing rad ...... ing mechanisms of interaction.
@en
P2093
P1476
Tumor response to ionizing rad ...... ring mechanisms of interaction
@en
P2093
Adam P Dicker
Phyllis Wachsberger
Randy Burd
P304
P407
P577
2003-06-01T00:00:00Z